Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04262154
Title Study of Abiraterone Acetate, Atezolizumab, Lupron, and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center

prostate adenocarcinoma


Abiraterone + Atezolizumab + Leuprolide + Prednisone

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.